Palvella Therapeutics (PVLA) Other Gross PP&E Adjustments (2016 - 2023)
Historic Other Gross PP&E Adjustments for Palvella Therapeutics (PVLA) over the last 11 years, with Q4 2023 value amounting to -$960000.0.
- Palvella Therapeutics' Other Gross PP&E Adjustments fell 10418.59% to -$960000.0 in Q4 2023 from the same period last year, while for Sep 2024 it was -$960000.0, marking a year-over-year change of. This contributed to the annual value of -$960000.0 for FY2023, which is 10418.59% down from last year.
- Per Palvella Therapeutics' latest filing, its Other Gross PP&E Adjustments stood at -$960000.0 for Q4 2023, which was down 10418.59% from $22.9 million recorded in Q2 2023.
- Palvella Therapeutics' Other Gross PP&E Adjustments' 5-year high stood at $23.9 million during Q4 2020, with a 5-year trough of -$960000.0 in Q4 2023.
- Over the past 5 years, Palvella Therapeutics' median Other Gross PP&E Adjustments value was $22.6 million (recorded in 2020), while the average stood at $19.4 million.
- Per our database at Business Quant, Palvella Therapeutics' Other Gross PP&E Adjustments surged by 15514.08% in 2020 and then plummeted by 10418.59% in 2023.
- Palvella Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at $19.6 million in 2019, then rose by 21.87% to $23.9 million in 2020, then fell by 4.17% to $22.9 million in 2021, then increased by 0.02% to $22.9 million in 2022, then plummeted by 104.19% to -$960000.0 in 2023.
- Its last three reported values are -$960000.0 in Q4 2023, $22.9 million for Q2 2023, and $22.9 million during Q1 2023.